This training will be relevant to both QIAGEN Main and Genomics workbench users and prospects who are interested in below analytics. Alignment and tree construction Sanger sequencing analysis Cloning and primer design Other molecular biology tools Register for the event.
While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data sources such as The Cancer Genome Atlas (TCGA), such investigation is hindered by difficulties in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high-quality curated genomic repositories such as […]
In this training, you will learn how to analyze and interpret your own single cell RNA-seq data using QIAGEN CLC Genomics Workbench starting with either FASTQ or matrix files. Using CLC Genomics Workbench, you will learn how to perform secondary analysis on your single cell RNA-seq data. Specifically, you will learn how to: Import your […]
In the drug discovery pipeline, evaluating multiple pathways between a drug target and disease is crucial for identifying potential therapeutic approaches. By examining overlapping pathways between competing drugs, researchers can uncover novel drug targets, while isoform-specific findings may elucidate unexpected clinical trial outcomes. Filtering these pathways with real-world expression and proteomics data is essential to […]
Disease pathogenesis is often context-dependent, specifically on tissue expression profiles within a given disease context. However, tissue expression profile of drug targets or potential targets is often difficult to ascertain. In this webinar, we will dive deep into the wealth of available deeply curated high quality ‘omics data (RNA-seq, scRNA-seq and more) in the OmicSoft […]
This is the description that will appear on the webinar page. I want to ensure that it is long enough to show really what happens when we put some really very long text in here for testing. There could be an entire article. Oh and maybe we add new line break?
There were 2 just there. Maybe those change things? Lets get this out and tested.
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships […]
Watch Now
